Form 4 · Filed Jul 20, 2026, 10:00 AM UTC
MLPT/MapLight Therapeutics, Inc.
GILLIS JONATHAN — CAO and Interim CFO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | S | sell | 16,969 | $38 | $638,204 | 145,140 |
| Jul 17, 2026 | S | sell | 600 | $37 | $21,906 | 162,109 |
| Jul 17, 2026 | S | sell | 900 | $38 | $34,353 | 144,240 |
| Jul 16, 2026 | S | sell | 1,476 | $37 | $55,261 | 162,709 |
| Jul 16, 2026 | S | sell | 6,979 | $37 | $255,850 | 164,185 |
| Jul 15, 2026 | S | sell | 5,356 | $36 | $193,512 | 175,863 |
| Jul 15, 2026 | S | sell | 4,699 | $37 | $173,581 | 171,164 |
Source: SEC EDGAR raw filing ↗ · Accession 0001709954-26-000010